Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paraconduit hernia after minimally invasive esophagectomy.

Journal of visualized surgery·2026
Same author

Mechanistic insights into profenofos interactions with antioxidant enzymes in Labeo rohita.

Aquatic toxicology (Amsterdam, Netherlands)·2026
Same author

Frequency of Hyponatremia in Patients With Chronic Liver Disease Presenting to the Outpatient Department: A Cross-Sectional Study.

Cureus·2026
Same author

An enhanced state convergence architecture incorporating disturbance observer for bilateral teleoperation systems.

International journal of advanced robotic systems·2026
Same author

Thermodynamic stability and optoelectronic property modulation of KTaO<sub>3</sub> via substitutional doping with Sr, Ba, La and Pr.

Scientific reports·2026
Same author

Density-Functional Theory Shows 2<i>H</i>‑Tetraphenylporphyrin Prefers Physisorption over Chemical Bonding on Ag(111).

ACS omega·2026

Related Experiment Video

Updated: Jun 11, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Esophageal cancer: an update.

C M Shahbaz Sarwar1, James D Luketich, Rodney J Landreneau

  • 1Heart, Lung & Esopahgeal Surgery Institute, University of Pittsburgh Medical Center, C-800 PUH, 200 Lothrop Street, Pittsburgh, PA 15213, USA.

International Journal of Surgery (London, England)
|July 6, 2010
PubMed
Summary

Esophageal cancer, particularly adenocarcinoma, is often diagnosed at advanced stages. This review updates management options and details minimally invasive esophagectomy techniques for improved patient outcomes.

More Related Videos

Establishment of Tumor Organoids, Carcinoma-Associated Fibroblasts, and Counterpart Fibroblasts from the Same Esophageal Cancer Patient
06:51

Establishment of Tumor Organoids, Carcinoma-Associated Fibroblasts, and Counterpart Fibroblasts from the Same Esophageal Cancer Patient

Published on: April 3, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Establishment of Tumor Organoids, Carcinoma-Associated Fibroblasts, and Counterpart Fibroblasts from the Same Esophageal Cancer Patient
06:51

Establishment of Tumor Organoids, Carcinoma-Associated Fibroblasts, and Counterpart Fibroblasts from the Same Esophageal Cancer Patient

Published on: April 3, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Innovation

Background:

  • Esophageal cancer presents a significant mortality challenge, frequently diagnosed in advanced stages.
  • Rising incidence of esophageal adenocarcinoma and undefined carcinogenic pathways from Barrett's esophagus.
  • Current locoregional treatments involve surgery, chemotherapy, and radiation therapy, often in combination.

Purpose of the Study:

  • To provide an updated overview of esophageal cancer management strategies.
  • To detail the surgical technique for minimally invasive esophagectomy.
  • To emphasize optimal surgical treatment principles including patient selection and staging.

Main Methods:

  • Review of current literature on esophageal cancer management.
  • Description of a specific minimally invasive esophagectomy surgical technique.
  • Discussion of multimodality treatment approaches.

Main Results:

  • Esophageal cancer management requires careful patient selection, accurate staging, and appropriate surgical approach.
  • Minimally invasive esophagectomy is a key surgical option.
  • Multimodality treatment is crucial for optimal outcomes.

Conclusions:

  • Optimal management of esophageal cancer hinges on a comprehensive approach integrating surgical expertise and multimodality care.
  • Minimally invasive esophagectomy offers a viable surgical option.
  • Further research into adenocarcinoma development pathways is warranted.